Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-17-041339)

Filing Details

Accession Number:: 0001104659-17-041339
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-06-23 17:20:41
Reporting Period:: 2017-06-23

Filing Date:: 2017-06-23
Accepted Time:: 2017-06-23 17:20:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1660719	Aralez Pharmaceuticals Inc.	ARLZ	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1646300	Eric Trachtenberg	C/O Aralez Pharmaceuticals Inc., 7100 West Credit Avenue, Suite 101 Mississauga A6 L5N 0E4	Gc, Cco & Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares, Without Par Value	Disposition	2017-06-23	7,720	$1.33	201,564	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 25,000 restricted stock units, which vested on June 22, 2017. 6,250 of such restricted stock units were previously granted on June 22, 2015 and 18,750 of such restricted stock units were previously granted on February 12, 2016.